FDA Inspection 813958 — Interpore Cross International, LLC

Interpore Cross International, LLC — FEI 1000160576

The FDA completed an inspection of Interpore Cross International, LLC on Jan 23, 2013 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 23, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1471021 CFR 820.150Lack of or inadequate procedures for storage.
326621 CFR 820.86Acceptance status